Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,953,000 | 2,098,600 | 1,172,300 | 508,700 | 2,662,700 |
| Depreciation Amortization | 1,047,900 | 773,100 | 507,600 | 245,100 | 801,800 |
| Income taxes - deferred | 60,700 | -283,100 | -464,800 | -289,600 | 346,800 |
| Accounts receivable | -842,700 | N/A | N/A | N/A | 243,900 |
| Accounts payable and accrued liabilities | 990,400 | N/A | N/A | N/A | -936,000 |
| Other Working Capital | -53,800 | -621,500 | -544,500 | -35,600 | -795,300 |
| Other Operating Activity | 999,000 | 957,700 | 809,700 | 463,200 | 1,652,000 |
| Operating Cash Flow | $5,154,500 | $2,924,800 | $1,480,300 | $891,800 | $3,975,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -376,900 | -225,200 | 63,700 | -15,400 | 1,247,500 |
| PPE Investments | -1,050,100 | -715,700 | -485,600 | -239,400 | -1,012,600 |
| Net Acquisitions | -2,673,200 | -2,667,500 | -2,579,900 | -2,225,600 | N/A |
| Purchase Of Investment | -750,700 | -471,300 | -358,200 | -210,200 | -1,313,200 |
| Sale Of Investment | 800,100 | 924,700 | 811,400 | 267,100 | 1,507,700 |
| Other Investing Activity | -277,300 | -109,000 | -59,700 | -31,800 | 179,000 |
| Investing Cash Flow | $-4,328,100 | $-3,264,000 | $-2,608,300 | $-2,455,300 | $608,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -468,500 | -432,100 | -372,900 | -3,900 | -8,400 |
| Debt Issued | 2,512,600 | 1,442,300 | 1,497,800 | 1,402,800 | N/A |
| Debt Repayment | -1,059,500 | N/A | N/A | N/A | -2,781,500 |
| Common Stock Issued | N/A | 21,600 | N/A | 7,600 | 59,600 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -122,100 |
| Dividend Paid | -1,853,600 | -1,389,800 | -926,500 | -462,900 | -1,736,300 |
| Other Financing Activity | 24,100 | 3,800 | 20,600 | 0 | 9,900 |
| Financing Cash Flow | $-844,900 | $-354,200 | $219,000 | $943,600 | $-4,578,800 |
| Exchange Rate Effect | 129,700 | 79,600 | 20,200 | 2,000 | 97,100 |
| Beginning Cash Position | 3,109,300 | 3,109,300 | 3,109,300 | 3,109,300 | 3,006,700 |
| End Cash Position | 3,220,500 | 2,495,500 | 2,220,500 | 2,491,400 | 3,109,300 |
| Net Cash Flow | $111,200 | $-613,800 | $-888,800 | $-617,900 | $102,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,154,500 | 2,924,800 | 1,480,300 | 891,800 | 3,975,900 |
| Capital Expenditure | -1,082,400 | -715,700 | -485,600 | -239,400 | -1,077,800 |
| Free Cash Flow | 4,072,100 | 2,209,100 | 994,700 | 652,400 | 2,898,100 |